Stem Holdings Inc(STMH)
USD --+0.00%
Reward44Moderate
Risk55Medium-High
📊75%Data
Revenue down 8% YoY
STMH
+0.0 · +0.00%
USD · OTCQB
Stem Holdings Inc | Healthcare
Earnings Deterioration
Market Cap:666
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
55
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on STMH to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $3.25.

What is Stem Holdings Inc?

Previously, the company operated as a vertically-integrated cannabis products and technology company.

STMH · Verdict

Moderate reward · elevated risk

STMH's standout is volatility; profitability and balance sheet weigh on the picture.

Based on 88% data coverage

STMH · Verdict

What’s working & what to watch

Strengths 1

  • Volatility75/100

    Above average

Watchouts 3

  • Profitability10/100

    -63% return on equity

  • Balance sheet34/100

    Current ratio 0.95

  • Cash flow42/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Stem Holdings Inc?

Previously, the company operated as a vertically-integrated cannabis products and technology company. Its brands include TJ's Gardens, TravisxJames, and Yerba Buena flower and extracts; Cannavor edible confections; and e-commerce delivery platforms provided direct-to consumer proprietary logistics and an omnichannel UX (user experience)/CX (customer experience). The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 666.00.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap666.00
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0001
52 Week LowN/A
Last AnnualSeptember
IPO DateN/A
IncorporatedUSA
Shares Outstanding7M
No. of Employees75
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTCQB
Beta-24.868
CurrencyUSD